Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes.
Scientific Reports
Ohnami, Sumiko S; Naruoka, Akane A; Isaka, Mitsuhiro M; Mizuguchi, Maki M; Nakatani, Sou S; Kamada, Fukumi F; Shimoda, Yuji Y; Sakai, Ai A; Ohshima, Keiichi K; Hatakeyama, Keiichi K; Maruyama, Kouji K; Ohde, Yasuhisa Y; Kenmotsu, Hirotsugu H; Takahashi, Toshiaki T; Akiyama, Yasuto Y; Nagashima, Takeshi T; Urakami, Kenichi K; Ohnami, Shumpei S; Yamaguchi, Ken K
Publication Date: 2022-10-26
Variant appearance in text: CDA: Ala70Thr; rs60369023
Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives.
Pharmaceutics
Pinto-Merino, Álvaro Á; Labrador, Jorge J; Zubiaur, Pablo P; Alcaraz, Raquel R; Herrero, María José MJ; Montesinos, Pau P; Abad-Santos, Francisco F; Saiz-Rodríguez, Miriam M
Publication Date: 2022-03-03
Variant appearance in text: CDA: 208G>A; rs60369023
The Extent and Impact of Variation in ADME Genes in Sub-Saharan African Populations.
Frontiers In Pharmacology
da Rocha, Jorge E B JEB; Othman, Houcemeddine H; Botha, Gerrit G; Cottino, Laura L; Twesigomwe, David D; Ahmed, Samah S; Drögemöller, Britt I BI; Fadlelmola, Faisal M FM; Machanick, Philip P; Mbiyavanga, Mamana M; Panji, Sumir S; Wright, Galen E B GEB; Adebamowo, Clement C; Matshaba, Mogomotsi M; Ramsay, Michéle M; Simo, Gustave G; Simuunza, Martin C MC; Tiemessen, Caroline T CT; Baldwin, Sandra S; Chiano, Mathias M; Cox, Charles C; Gross, Annette S AS; Thomas, Pamela P; Gamo, Francisco-Javier FJ; Hazelhurst, Scott S
Population Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Patients with Adrenocortical Carcinoma: Towards Individualized Dosing.
Clinical Pharmacokinetics
Yin, Anyue A; Ettaieb, Madeleine H T MHT; Swen, Jesse J JJ; van Deun, Liselotte L; Kerkhofs, Thomas M A TMA; van der Straaten, Robert J H M RJHM; Corssmit, Eleonora P M EPM; Gelderblom, Hans H; Kerstens, Michiel N MN; Feelders, Richard A RA; Eekhoff, Marelise M; Timmers, Henri J L M HJLM; D'Avolio, Antonio A; Cusato, Jessica J; Guchelaar, Henk-Jan HJ; Haak, Harm R HR; Moes, Dirk Jan A R DJAR
Publication Date: 2021-01
Variant appearance in text: CDA: 208G>A; A70T; rs60369023
Determinants of the interindividual variability in serum cytidine deaminase activity of patients with solid tumours.
British Journal Of Clinical Pharmacology
Cohen, R R; Preta, L H LH; Joste, V V; Curis, E E; Huillard, O O; Jouinot, A A; Narjoz, C C; Thomas-Schoemann, A A; Bellesoeur, A A; Tiako Meyo, M M; Quilichini, J J; Desaulle, D D; Nicolis, I I; Cessot, A A; Vidal, M M; Goldwasser, F F; Alexandre, J J; Blanchet, B B
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
Nature Communications
Dufva, Olli O; Kankainen, Matti M; Kelkka, Tiina T; Sekiguchi, Nodoka N; Awad, Shady Adnan SA; Eldfors, Samuli S; Yadav, Bhagwan B; Kuusanmäki, Heikki H; Malani, Disha D; Andersson, Emma I EI; Pietarinen, Paavo P; Saikko, Leena L; Kovanen, Panu E PE; Ojala, Teija T; Lee, Dean A DA; Loughran, Thomas P TP; Nakazawa, Hideyuki H; Suzumiya, Junji J; Suzuki, Ritsuro R; Ko, Young Hyeh YH; Kim, Won Seog WS; Chuang, Shih-Sung SS; Aittokallio, Tero T; Chan, Wing C WC; Ohshima, Koichi K; Ishida, Fumihiro F; Mustjoki, Satu S
Impact of Polymorphic Variations of Gemcitabine Metabolism, DNA Damage Repair, and Drug-Resistance Genes on the Effect of High-Dose Chemotherapy for Relapsed or Refractory Lymphoid Malignancies.
Biology Of Blood And Marrow Transplantation : Journal Of The American Society For Blood And Marrow Transplantation
Shinozuka, Keiji K; Tang, Hongwei H; Jones, Roy B RB; Li, Donghui D; Nieto, Yago Y
The Affymetrix DMET Plus platform reveals unique distribution of ADME-related variants in ethnic Arabs.
Disease Markers
Wakil, Salma M SM; Nguyen, Cao C; Muiya, Nzioka P NP; Andres, Editha E; Lykowska-Tarnowska, Agnieszka A; Baz, Batoul B; Tahir, Asma I AI; Meyer, Brian F BF; Morahan, Grant G; Dzimiri, Nduna N
Alvarellos, Maria L ML; Lamba, Jatinder J; Sangkuhl, Katrin K; Thorn, Caroline F CF; Wang, Liewei L; Klein, Daniel J DJ; Altman, Russ B RB; Klein, Teri E TE
Publication Date: 2014-11
Variant appearance in text: CDA: Ala70Thr; rs60369023
Screening for 392 polymorphisms in 141 pharmacogenes.
Biomedical Reports
Kim, Jason Yongha JY; Cheong, Hyun Sub HS; Park, Tae-Joon TJ; Shin, Hee Jung HJ; Seo, Doo Won DW; Na, Han Sung HS; Chung, Myeon Woo MW; Shin, Hyoung Doo HD
Publication Date: 2014-07
Variant appearance in text: CDA: 208G>A; Ala70Thr; rs60369023
Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.
Cancer
Tanaka, Motofumi M; Javle, Milind M; Dong, Xiaoqun X; Eng, Cathy C; Abbruzzese, James L JL; Li, Donghui D
Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism.
European Journal Of Clinical Pharmacology
Maring, Jan Gerard JG; Wachters, Floris M FM; Slijfer, Monique M; Maurer, J Marina JM; Boezen, H Marike HM; Uges, Donald R A DR; de Vries, Elisabeth G E EG; Groen, Harry J M HJ
Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients.
British Journal Of Cancer
Ueno, H H; Kaniwa, N N; Okusaka, T T; Ikeda, M M; Morizane, C C; Kondo, S S; Sugiyama, E E; Kim, S R SR; Hasegawa, R R; Saito, Y Y; Yoshida, T T; Saijo, N N; Sawada, J J
Publication Date: 2009-03-24
Variant appearance in text: CDA: Ala70Thr; rs60369023